Prevalence of subtype-related polymorphisms associated with in vitro resistance to attachment inhibitor BMS-626529 in HIV-1 ‘non-B’-infected patients.

MLA

Charpentier, Charlotte, et al. “Prevalence of Subtype-Related Polymorphisms Associated with in Vitro Resistance to Attachment Inhibitor BMS-626529 in HIV-1 ‘Non-B’-Infected Patients.” Journal of Antimicrobial Chemotherapy (JAC), vol. 67, no. 6, June 2012, pp. 1459–61. EBSCOhost, https://doi.org/10.1093/jac/dks067.

APA

Charpentier, C., Larrouy, L., Visseaux, B., Landman, R., Levittas, M., Storto, A., Damond, F., Yazdanpanah, Y., Yeni, P., Brun-Vézinet, F., & Descamps, D. (2012). Prevalence of subtype-related polymorphisms associated with in vitro resistance to attachment inhibitor BMS-626529 in HIV-1 ‘non-B’-infected patients. Journal of Antimicrobial Chemotherapy (JAC), 67(6), 1459–1461. https://doi.org/10.1093/jac/dks067

Chicago

Charpentier, Charlotte, Lucile Larrouy, Benoit Visseaux, Roland Landman, Marine Levittas, Alexandre Storto, Florence Damond, et al. 2012. “Prevalence of Subtype-Related Polymorphisms Associated with in Vitro Resistance to Attachment Inhibitor BMS-626529 in HIV-1 ‘Non-B’-Infected Patients.” Journal of Antimicrobial Chemotherapy (JAC) 67 (6): 1459–61. doi:10.1093/jac/dks067.